Vanguard Fiduciary Trust
NNVC icon

Vanguard Fiduciary Trust’s NanoViricides NNVC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
131,923
+41,863
+46% +$57.4K ﹤0.01% 3602
2026
Q1 		$82.1K Buy
+90,060
New +$94.3K ﹤0.01% 3744

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's NNVC Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its NanoViricides (NNVC) stake by 46% in Q2 2026, buying an estimated $57.4K and bringing the position to 131,923 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

Vanguard Fiduciary Trust first reported a position in NNVC in Q1 2026 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Vanguard Fiduciary Trust held 131,923 shares of NanoViricides worth $182K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 41,863 NanoViricides shares in Q2 2026, an estimated $57.4K.
  • NanoViricides made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3602 holding.
  • Vanguard Fiduciary Trust first reported a position in NanoViricides in Q1 2026 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.